This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Are Bullish on Top Healthcare Stocks: Alkermes (ALKS), Baxter International (BAX)

Tipranks - Tipranks - Mon May 4, 8:28PM CDT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alkermes (ALKS) and Baxter International (BAX) with bullish sentiments.

Claim 55% Off TipRanks

Alkermes (ALKS)

In a report released yesterday, Uy Ear from Mizuho Securities reiterated a Buy rating on Alkermes, with a price target of $53.00. The company’s shares closed last Friday at $33.38.

According to TipRanks.com, Ear is a 2-star analyst with an average return of 0.2% and a 39.4% success rate. Ear covers the Healthcare sector, focusing on stocks such as Arcutis Biotherapeutics, ACADIA Pharmaceuticals, and Cartesian Therapeutics. ;'>

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Alkermes with a $45.36 average price target, representing a 35.7% upside. In a report issued on April 19, TipRanks – PerPlexity also reiterated a Buy rating on the stock with a $39.00 price target.

See today’s best-performing stocks on TipRanks >>

Baxter International (BAX)

Barclays analyst Matt Miksic maintained a Buy rating on Baxter International on May 1 and set a price target of $27.00. The company’s shares closed last Friday at $17.21.

According to TipRanks.com, Miksic is a 3-star analyst with an average return of 1.8% and a 49.4% success rate. Miksic covers the Healthcare sector, focusing on stocks such as Anteris Technologies Global Corp., GE Healthcare Technologies Inc, and Bausch + Lomb Corporation. ;'>

Baxter International has an analyst consensus of Hold, with a price target consensus of $20.00.

Read More on ALKS:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).